BrightView Holdings, Inc., through its subsidiaries, provides commercial landscaping services in the United States. It operates in two segments, Maintenance Services and Development Services. The Maintenance Services segment delivers a suite of recurring commercial landscaping services, including mowing, gardening, mulching and snow removal, water management, irrigation maintenance, tree care, golf course maintenance, and specialty turf maintenance. Its customers' properties include corporate and commercial properties, homeowners associations, public parks, hotels and resorts, airport authorities, municipalities, hospitals and other healthcare facilities, educational institutions, restaurants and retail, and golf courses. This segment's customer base includes approximately 11,700 office parks and corporate campuses 10,000 residential communities, and 700 educational institutions. The Development Services segment offers landscape architecture and development services for new facilities and redesign projects. Its services include project design and management services, landscape architecture and installation, irrigation installation, tree moving and installation, pool and water features, sports field, and other services. BrightView Holdings, Inc. also operates as official field consultant to Major League Baseball. The company was formerly known as BrightView Acquisition Holdings, Inc. BrightView Holdings, Inc. was founded in 1939 and is headquartered in Blue Bell, Pennsylvania.

BrightView Holdings, Inc.

Migros Ticaret A.S. ( ($TR:MGROS) ) has provided an announcement. Migros Ticaret A.Ş. and Bülbüloğlu Vinç Sanayi ve Ticaret A.Ş. have disclosed to ...

Migros and Bülbüloğlu Vinç Shares Set to Convert Into Tradable Stock

Tera Yatirim Menkul Degerler AS ( ($TR:TERA) ) just unveiled an announcement. Tera Yatirim Menkul Degerler AS has applied to Borsa İstanbul to exec...

Tera Yatirim to Acquire 3% Bülbüloğlu Vinç Stake via Borsa İstanbul Wholesale Deal

The latest announcement is out from Banco Bilbao Vizcaya Argentaria ( ($ES:BBVA) ). BBVA has reported a significant event concerning its ongoing sh...

BBVA Publishes Periodic Report on Ongoing Share Buyback Program

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Annovis Bio (ANVS), AbbVie (ABBV) and Glaukos (GKOS)...

Analysts Are Bullish on Top Healthcare Stocks: Annovis Bio (ANVS), AbbVie (ABBV)

An update from Baronsmead Venture ( ($GB:BVT) ) is now available. Baronsmead Venture Trust PLC, a UK venture capital trust investing in smaller and...

Baronsmead Venture Trust Plans Joint £10m Fundraising with Sister VCT

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Legend Biotech (LEGN), Ionis Pharmaceuticals (IONS...

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Ionis Pharmaceuticals (IONS) and AbbVie (ABBV)

Nubeva Technologies Ltd ( ($TSE:NBVA) ) just unveiled an announcement. Nubeva Technologies Ltd. has secured access to a frontier artificial intelli...

Nubeva Gains Access to Frontier AI Model for Ransomware Defense

The latest update is out from DBV Technologies ( ($FR:DBV) ). DBV Technologies will engage investors at three major healthcare and biopharma confer...

DBV Technologies Steps Up Investor Outreach Ahead of Key Food Allergy Trial Milestones

Claranova SA ( ($FR:ALCLA) ) has issued an update. Claranova SE has disclosed its share capital structure as of August 31, 2026, reporting 57,206,9...

Claranova Updates Market on Share Capital and Voting Rights Structure

Hub Girisim Sermayesi Yatirim Ortakligi A.S. ( ($TR:HUBVC) ) has shared an announcement. Trading in HUBVC shares on Borsa Istanbul has been tempora...

HUBVC Trading Temporarily Shifted to Single-Price Auction After Circuit Breaker

Breville Group ( ($AU:BRG) ) just unveiled an update. Breville Group Limited has applied for quotation of 280,672 new ordinary fully paid shares on...

Breville Seeks ASX Quotation for 280,672 New Ordinary Shares

Breville Group ( ($AU:BRG) ) has provided an update. Breville Group Limited has applied to the ASX for quotation of 753,193 new fully paid ordinary...

Breville Seeks ASX Quotation for 753,193 New Ordinary Shares

DBV Technologies ( ($FR:DBV) ) has provided an update. DBV Technologies reported that its share capital comprised 314,388,807 shares as of August 3...

DBV Technologies Updates Share Capital and Voting Rights as of August 31, 2026

The latest announcement is out from Bureau Veritas ( ($FR:BVI) ). Bureau Veritas has completed a €700 million bond issuance with a 4.125% coupon, m...

Bureau Veritas Secures €700 Million Bond to Refinance Debt and Extend Maturities

The latest update is out from Bravura Solutions Limited ( ($AU:BVS) ). Bravura Solutions Limited has disclosed a late lodgement of an Appendix 3Y, ...

Bravura flags isolated late filing of director share change

The latest update is out from Nubeva Technologies Ltd ( ($TSE:NBVA) ). Nubeva Technologies Ltd., a ransomware-focused cybersecurity firm, has elect...

Nubeva Moves to Semi-Annual Reporting to Streamline Compliance

In a report released today, Rebecca Parker from Goldman Sachs maintained a Buy rating on Vistry Group, with a price target of p355.00. Parker cover...

Goldman Sachs Reaffirms Their Buy Rating on Vistry Group (VTY)

Banco Bilbao ( ($BBVA) ) just unveiled an announcement. BBVA has reported progress on the first tranche of its previously announced share buyback p...

BBVA Reaches Midpoint of First Tranche in € Share Buyback Program

BULBULOGLU VINC SANAYI VE TICARET A.S. ( ($TR:BVSAN) ) has issued an announcement. Bulbuloglu Vinc Sanayi ve Ticaret A.S., a crane manufacturing an...

Bulbuloglu Vinc Secures €1.06 Million Crane Contract with Sami Trafo

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) has posted a new Phase 3 trial plan for its drug etentamig in amy...

AbbVie Targets Rare Blood Disorder With New Phase 3 Etentamig Trial Plan

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) is running a new Phase 2 platform basket study called “A Phase 2 ...

AbbVie Expands Its IBD Pipeline With New Phase 2 Basket Trial in Crohn’s and Ulcerative Colitis

ABVC BioPharma ( ($ABVC) ) has issued an announcement. On August 21, 2026, ABVC BioPharma completed the legal and structural separation of its subs...

ABVC BioPharma Completes BioKey Cayman Spin-Off Transaction

PAC Partners analyst Nick Maxwell maintained a Buy rating on Advanced Braking Technology Limited yesterday. The company’s shares closed today at A$...

PAC Partners Sticks to Its Buy Rating for Advanced Braking Technology Limited (ABV)

Top Glove Bhd ( ($TPGVF) ) has provided an announcement. Top Glove Corporation Bhd has issued 750 new ordinary shares through the conversion of war...

Top Glove Lifts Issued Share Capital Through Warrant Conversion

Bravura Solutions Limited (($AU:BVS)) has held its Q4 earnings call. Read on for the main highlights of the call. Bravura Solutions’ latest earning...

Bravura Solutions Signals Profitable Momentum In FY2026

Advanced Braking Technology Limited ( ($AU:ABV) ) has provided an update. Advanced Braking Technology reported record FY26 revenue of $23.5 million...

Advanced Braking Technology posts record revenue and boosts margins in FY26

An announcement from Banco Bilbao ( ($BBVA) ) is now available. BBVA, a leading Spanish banking group with extensive retail and corporate operation...

BBVA Advances First Tranche of Share Buyback Program

Vistry Group ( ($GB:VTY) ) has shared an update. Vistry Group PLC has been reconfirmed as a Strategic Partner in the U.K. government’s £39bn Social...

Vistry wins £350m grant to accelerate affordable housing delivery

The latest update is out from Hub Girisim Sermayesi Yatirim Ortakligi A.S. ( ($TR:HUBVC) ). Hub Girisim Sermayesi Yatirim Ortakligi A.S., a Turkish...

Hub Girisim Secures Settlement on USD 318,600 Dispute With Rem

Banco Bilbao Vizcaya Argentaria ( ($ES:BBVA) ) has provided an announcement. BBVA has reported a significant event concerning its ongoing share buy...

BBVA Publishes Periodic Report on Share Buyback Program

Prestige Consumer Healthcare (($PBH)) has held its Q1 earnings call. Read on for the main highlights of the call. Prestige Consumer Healthcare’s la...

Prestige Consumer Healthcare Lifts Outlook After Strong Q1

Insiders have been trading these 5 stocks: (($JNJ)), (($ABBV)), (($CVX)), (($ET)) and (($HD)). Here is a breakdown of their recent trades and their...

Johnson & Johnson, AbbVie, Chevron, Energy Transfer, Home Depot Shaken

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie is running a Phase 2 study called “A Phase 2 Open-Label Study to Evaluat...

AbbVie Expands Aesthetics Pipeline With New Phase 2 Forehead Lines Study

Abbvie ($ABBV) announced an update on their ongoing clinical study. The Phase 3 study “A Phase 3 Randomized, Placebo-controlled, Double-blind Study...

AbbVie Targets Pediatric Alopecia With New Phase 3 Trial: What Investors Should Watch

Bioventus, Inc. (($BVS)) has held its Q2 earnings call. Read on for the main highlights of the call. Bioventus, Inc. struck an upbeat tone on its l...

Bioventus Earnings Call Highlights Growth Amid Review

An announcement from Advanced Braking Technology Limited ( ($AU:ABV) ) is now available. Advanced Braking Technology Ltd will host an investor webi...

Advanced Braking Technology to Brief Investors on FY26 Results via Webinar

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) is launching a Phase 1 study called “A Phase 1 Study to Evaluate ...

AbbVie Targets Next-Gen BOTOX Combo With New Glabellar Lines Study

Jarden analyst Apoorv Sehgal maintained a Buy rating on Breville Group today and set a price target of A$34.90. According to TipRanks, Sehgal is ra...

Jarden Keeps Their Buy Rating on Breville Group  (BVILF)

Claranova SA ( ($FR:ALCLA) ) has shared an update. Claranova’s Avanquest division has signed a distribution agreement with Vertosoft, a major suppl...

Claranova’s Avanquest taps U.S. public-sector growth via Vertosoft deal

BULBULOGLU VINC SANAYI VE TICARET A.S. ( ($TR:BVSAN) ) has shared an announcement. Bulbuloglu Vinc Sanayi ve Ticaret A.S. has published a Participa...

Bulbuloglu Vinc Details Participation Finance Compliance in 2026 Half‑Year Report

Bouvet ASA ( ($DE:BV4) ) has issued an announcement. Bouvet ASA reported second-quarter 2026 operating revenues of NOK 975.0 million, slightly abov...

Bouvet posts solid Q2 revenues amid margin pressure and continued Nordic expansion

Citi analyst Sam Teeger maintained a Buy rating on Breville Group today and set a price target of A$39.65. Teeger covers the Consumer Cyclical sect...

Breville Group  (BVILF) Receives a Buy from Citi

Itau Unibanco ( ($ITUB) ) has shared an announcement. Itaú Unibanco has received conditional preliminary approval from the U.S. Office of the Compt...

Itaú Unibanco Wins Preliminary U.S. Approval to Launch National Bank

J.P. Morgan analyst Marta Sanchez Romero maintained a Buy rating on Banco Bilbao Vizcaya Argentaria today and set a price target of €26.80. Accordi...

J.P. Morgan Keeps Their Buy Rating on Banco Bilbao Vizcaya Argentaria (BVA)

An update from Tao Heung Holdings Limited ( ($HK:0573) ) is now available. Tao Heung Holdings Limited has scheduled a board meeting for 27 August 2...

Tao Heung Board Sets August Meeting to Approve Interim Results and Dividend

Bravura Solutions Limited ( ($AU:BVS) ) has shared an announcement. Bravura Solutions Limited has notified the market of the issue and conversion o...

Bravura Solutions Updates Market on Issue and Conversion of Unquoted Securities

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) is expanding its push into Alzheimer’s with a new study titled “A...

AbbVie Steps Deeper Into Alzheimer’s: What the ABBV-1758 Trial Means for Investors

In a report released today, Manuela Stuerzer from Deutsche Bank maintained a Buy rating on verbio Vereinigte BioEnergie, with a price target of €42...

Deutsche Bank  Keeps Their Buy Rating on verbio Vereinigte BioEnergie (0NLY)

Barak Valley Cements Limited ( ($IN:BVCL) ) has shared an announcement. Barak Valley Cements Limited has released its unaudited financial results f...

Barak Valley Cements Publishes Q1 FY27 Unaudited Results in Line with SEBI Norms

An announcement from Bravura Solutions Limited ( ($AU:BVS) ) is now available. Bravura Solutions has announced senior leadership changes, with form...

Bravura Solutions Reshapes Finance and Governance Leadership

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Liquidia Technologies (LQDA), AbbVie (ABBV) and Esta...

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)

In a report released yesterday, Cameron Halkett from Canaccord Genuity maintained a Buy rating on Bravura Solutions Limited, with a price target of...

Canaccord Genuity Reaffirms Their Buy Rating on Bravura Solutions Limited (BVS)

Shaw and Partners analyst Jules Cooper maintained a Buy rating on Bravura Solutions Limited today and set a price target of A$3.30. According to Ti...

Bravura Solutions Limited (BVS) Receives a Buy from Shaw and Partners

In a report released today, from Macquarie maintained a Hold rating on Bravura Solutions Limited, with a price target of A$3.30. Bravura Solutions ...

Macquarie Sticks to Their Hold Rating for Bravura Solutions Limited (BVS)

Abivax SA ( ($FR:ABVX) ) has provided an update. Abivax reported that as of July 31, 2026, its share capital consists of 87,253,797 shares, corresp...

Abivax Updates Share Capital and Voting Rights as of July 31, 2026

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie’s phase 3 study, BOTOX® (onabotulinumtoxinA) for the Reduction of Masset...

AbbVie’s BOTOX Jawline Trial Wraps Up: What the Masseter Study Means for ABBV Investors

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie’s latest update covers a completed early study testing venetoclax with a...

AbbVie’s Venetoclax Combo in High-Risk MDS: What a Fresh Trial Update Signals for Investors

Banco Bilbao ( ($BBVA) ) has provided an update. BBVA has provided an update on the execution of the first tranche of its share buyback programme, ...

BBVA Advances First Tranche of Share Buyback Programme

Banco Bilbao Vizcaya Argentaria ( ($ES:BBVA) ) has shared an update. BBVA has released a periodic report on its ongoing share buyback program, disc...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BV	$11.36	+0.26%	628.09K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BV	$11.36	+0.3%	628.09K
3
4
5
6

BV

Get BrightView Holdings, Inc. Data in Excel

Get BrightView Holdings, Inc. Data in Excel